Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Boston Scientific Corporation BSX |
BLACKROCK INC BLK |
113,006,671 7.600% |
-14,029,994 (-11.04%) |
Filing History |
| 2025-04-07 10:14 am Purchase |
2023-12-29 | 13G | Boston Scientific Corporation BSX |
FMR CORP | 141,149,782 9.600% |
1,547,043 (+1.11%) |
Filing History |
| 2024-02-13 5:00 pm Purchase |
2023-12-29 | 13G | Boston Scientific Corporation BSX |
The Vanguard Group | 125,449,595 8.560% |
6,675,801 (+5.62%) |
Filing History |
| 2024-02-09 11:49 am Sale |
2024-02-09 | 13G | Boston Scientific Corporation BSX |
MASSACHUSETTS FINANCIAL SERVICES CO | 57,175,974 3.900% |
-25,291,495 (-30.67%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Boston Scientific Corporation BSX |
FMR CORP | 139,602,739 9.529% |
34,349,164 (+32.63%) |
Filing History |
| 2024-01-25 1:48 pm Sale |
2023-12-31 | 13G | Boston Scientific Corporation BSX |
BLACKROCK INC BLK |
127,036,665 8.700% |
-10,765,981 (-7.81%) |
Filing History |
| 2023-02-14 11:31 am Sale |
2022-12-31 | 13G | Boston Scientific Corporation BSX |
BLACKROCK INC BLK |
137,802,646 9.600% |
-2,313,619 (-1.65%) |
Filing History |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Boston Scientific Corporation BSX |
The Vanguard Group | 118,773,794 8.290% |
7,152,164 (+6.41%) |
Filing History |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | Boston Scientific Corporation BSX |
FMR CORP | 105,253,575 7.343% |
5,174,008 (+5.17%) |
Filing History |
| 2023-02-08 4:07 pm Sale |
2023-02-08 | 13G | Boston Scientific Corporation BSX |
MASSACHUSETTS FINANCIAL SERVICES CO | 82,467,469 5.800% |
-4,176,859 (-4.82%) |
Filing History |
| 2023-02-06 2:59 pm Sale |
2022-12-30 | 13G | Boston Scientific Corporation BSX |
WELLINGTON MANAGEMENT CO LLP | 57,736,340 4.030% |
-16,685,169 (-22.42%) |
Filing History |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Boston Scientific Corporation BSX |
BLACKROCK INC BLK |
140,116,265 9.800% |
12,198,610 (+9.54%) |
Filing History |
| 2022-02-10 4:03 pm Purchase |
2021-12-31 | 13G | RenovoRx, Inc. RNXT |
BOSTON SCIENTIFIC CORP BSX |
543,971 6.106% |
543,971 (New Position) |
Filing History |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Boston Scientific Corporation BSX |
The Vanguard Group | 111,621,630 7.830% |
840,472 (+0.76%) |
Filing History |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | Boston Scientific Corporation BSX |
FMR CORP | 100,079,567 7.017% |
34,667,924 (+53.00%) |
Filing History |
| 2022-02-08 5:12 pm Sale |
2021-12-31 | 13G | Boston Scientific Corporation BSX |
BLACKROCK INC BLK |
127,917,655 9.000% |
-8,044,462 (-5.92%) |
Filing History |
| 2022-02-04 09:26 am Sale |
2021-12-31 | 13G | Boston Scientific Corporation BSX |
WELLINGTON MANAGEMENT CO LLP | 74,421,509 5.220% |
-2,844,132 (-3.68%) |
Filing History |
| 2022-02-03 4:01 pm Sale |
2021-12-31 | 13G | Pulmonx Corporation LUNG |
BOSTON SCIENTIFIC CORP BSX |
0 0.000% |
-5,988,106 (Position Closed) |
Filing History |
| 2022-02-02 12:46 pm Purchase |
2022-02-02 | 13G | Boston Scientific Corporation BSX |
MASSACHUSETTS FINANCIAL SERVICES CO | 86,644,328 6.100% |
86,644,328 (New Position) |
Filing History |
| 2021-02-16 1:24 pm Sale |
2021-02-16 | 13G | Boston Scientific Corporation BSX |
Capital World Investors | 7,359,271 0.500% |
-100,711,986 (-93.19%) |
Filing History |